NASDAQ:FIXX
Homology Medicines Inc. Stock News
$0.93
+0 (+0%)
At Close: May 17, 2024
Zacks: Brokerages Expect Homology Medicines Inc (NASDAQ:FIXX) Will Post Quarterly Sales of $470,000.00
02:44am, Wednesday, 17'th Jun 2020
Equities research analysts predict that Homology Medicines Inc (NASDAQ:FIXX) will post $470,000.00 in sales for the current quarter, according to Zacks Investment Research. Two analysts have provided
Fortress Biotech, Inc. (Nasdaq: FBIO) (“Fortress”), an innovative biopharmaceutical company focused on acquiring, developing and commercializing high-potential
Global Leukemia Therapeutics Market Forecast and Opportunities to 2025 - ResearchAndMarkets.com
12:00am, Thursday, 11'th Jun 2020
The
Repligen: Management Gambled With 2020 Guidance But Long-Term Growth Story Looks Compelling (NASDAQ:RGEN)
05:04pm, Wednesday, 10'th Jun 2020
Repligen develops and sells bioprocessing technologies and systems involved in the manufacturing of biological drugs. The company operates within a high growth,
IPO Update: Generation Bio Proposes IPO Terms (Pending:GBIO)
07:31pm, Tuesday, 09'th Jun 2020
Generation Bio has filed proposed terms for its $126 million IPO. The firm is advancing gene therapy treatment candidates for various diseases. GBIO is an extre
Somebody tell Mesoblast we get the message
01:31pm, Wednesday, 03'rd Jun 2020
Mesoblast has now put out at least nine announcements since April 9 covering the same potential treatment for COVID-19.
Generation Bio Begins U.S. IPO Rollout (Pending:GBIO)
04:07pm, Thursday, 28'th May 2020
Generation Bio has filed to raise $125 million in a U.S. IPO. The firm is a pre-clinical developer of genetic treatments for liver and retinal diseases. GBIO is
- Methods Showed Efficient On-Target Gene Integration with No Unintended DNA Modifications - BEDFORD, Mass., May 26, 2020 -- Homology Medicines, Inc. (Nasdaq: FIXX), a.
The Week Ahead In Biotech: ASCO Presentations In The Spotlight
12:00am, Sunday, 24'th May 2020
Biotech stocks closed the week ended May 22 higher, with stray clinical readouts and COVID-19 drug- and vaccine-related news moving stocks in the sector.
Surface Oncology Inc (...
City of Hope Physicians/Scientists Lead Multiple, Innovative COVID-19 Research Projects
12:00am, Thursday, 21'st May 2020
City of Hope’s physician-scientists and basic scientists are using their expertise to attack the deadly coronavirus on multiple research fronts.
7 Biotech Stocks Wall Street Says Will Double or More
08:08pm, Tuesday, 19'th May 2020
Bull market or bear market, one fact remains unwavering: Biotech stocks represent the ultimate risk/reward plays.These investments are inherently volatile in nature. Numerous biotechnology companies h
The
- Molecular Methods Quantified Precision and Efficiency of Nuclease-Free Gene Editing for PKU - - Manufacturing Enhancements Led to Improved Productivity, Quality and.
Atara Biotherapeutics Announces Appointment of Cell & Gene Therapy Expert Maria Grazia Roncarolo, MD to Board of Directors
12:00am, Monday, 11'th May 2020
Atara Biotherapeutics, Inc. (Nasdaq: ATRA), a pioneer in T-cell immunotherapy leveraging its novel allogeneic EBV T-cell platform to develop transform
Homology Medicines, Inc. (NASDAQ:FIXX) Consensus Forecasts Have Become A Little Darker Since Its Latest Report
01:45pm, Sunday, 10'th May 2020
The quarterly results for Homology Medicines, Inc. (NASDAQ:FIXX) were released last week, making it a good time to...
